10x Genomics, Inc. (TXG)
USD 13.42
(-8.83%)
USD 13.42
(-8.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.19 Million | -33.6 Million | -21.37 Million | -217.89 Million | 34.62 Million | -76.4 Million |
| Net Income | -255.09 Million | -166 Million | -58.22 Million | -542.73 Million | -31.25 Million | -112.48 Million |
| Depreciation & Amortization | 43.61 Million | 33 Million | 28.25 Million | 19.02 Million | 7.06 Million | 3.9 Million |
| Deferred income taxes | -262.94 Million | - | - | 1.55 Million | 614 Thousand | 251 Thousand |
| Stock-based compensation | 166.95 Million | 136.84 Million | 95.96 Million | 48.62 Million | 13.33 Million | 2.65 Million |
| Change in working capital | 17.34 Million | -39.41 Million | -87.44 Million | -50.38 Million | 44.76 Million | 28.01 Million |
| Other non-cash items | 274.93 Million | 1.95 Million | 79 Thousand | 306.01 Million | 101 Thousand | 1.24 Million |
| Investing Cash Flow | 133.49 Million | -350.88 Million | -106.72 Million | -38.39 Million | -42.76 Million | -6.7 Million |
| Investments in PPE | -49.52 Million | -131.66 Million | -101.27 Million | -38.39 Million | -42.76 Million | -6.7 Million |
| Acquisitions | - | -4 Million | -5.45 Million | - | - | - |
| Investment purchases | - | -282.87 Million | - | - | - | - |
| Sales/Maturities of investments | 183.01 Million | 67.64 Million | - | - | - | - |
| Other Investing Activities | -1.00 | -215.22 Million | - | -1.72 Million | -25 Thousand | -425 Thousand |
| Financing Cash Flow | 13.66 Million | 15.81 Million | 35.29 Million | 468.9 Million | 414.59 Million | 105.36 Million |
| Debt repayment | -5.81 Million | -5.4 Million | -5.02 Million | -37.1 Million | -11 Million | -773 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.48 Million | 21.22 Million | 40.32 Million | 506.01 Million | 410.82 Million | 1.79 Million |
| Other Financing Activities | -5.81 Million | -5.4 Million | -5.02 Million | 506.01 Million | 14.76 Million | 104.34 Million |
| Accounts receivables | -10.61 Million | -18.94 Million | -34.04 Million | -17.84 Million | -5.28 Million | -14.74 Million |
| Accounts payables | -6.01 Million | 5.85 Million | 11.08 Million | -7.77 Million | 4.9 Million | 2.58 Million |
| Inventory | 7.87 Million | -21.19 Million | -30.13 Million | -14.6 Million | -6.69 Million | -3.73 Million |
| Other working capital | 26.1 Million | -5.13 Million | -34.35 Million | -10.16 Million | 51.84 Million | 43.9 Million |
| Cash at beginning of period | 222.37 Million | 596.07 Million | 688.64 Million | 476.49 Million | 70.08 Million | 47.85 Million |
| Cash at end of period | 359.28 Million | 227.35 Million | 596.07 Million | 688.64 Million | 476.49 Million | 70.08 Million |
| Capital Expenditure | -49.52 Million | -131.66 Million | -101.27 Million | -38.39 Million | -42.76 Million | -6.7 Million |
| Effect of forex changes on cash | -33 Thousand | -44 Thousand | 234 Thousand | -463 Thousand | -45 Thousand | -18 Thousand |
| Net cash flow / Change in cash | 136.9 Million | -368.72 Million | -92.57 Million | 212.15 Million | 406.4 Million | 22.23 Million |
| Free Cash Flow | -64.72 Million | -165.26 Million | -122.65 Million | -256.29 Million | -8.14 Million | -83.11 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.75 Million | -37.89 Million | -59.94 Million | -48.95 Million | -255.09 Million | -92.98 Million |
| Depreciation & Amortization | 10.75 Million | 10.9 Million | 11.49 Million | 11.7 Million | 43.61 Million | 11.42 Million |
| Deferred income taxes | - | - | - | 23.85 Million | -262.94 Million | -26.63 Million |
| Stock-based compensation | 33.58 Million | 38.49 Million | 36.12 Million | 38.91 Million | 166.95 Million | 40.23 Million |
| Change in working capital | 12.99 Million | -4.06 Million | -6.29 Million | 17.06 Million | 17.34 Million | 16.17 Million |
| Other non-cash items | 64 Thousand | 64.31 Million | 43.85 Million | -16.83 Million | 274.93 Million | 26.49 Million |
| Investing Cash Flow | -3.61 Million | 11.94 Million | 10.63 Million | 13.09 Million | 133.49 Million | 4.9 Million |
| Investments in PPE | -3.88 Million | -3.87 Million | -2.91 Million | -3.45 Million | -49.52 Million | -15.43 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 271 Thousand | 15.82 Million | 13.54 Million | 16.54 Million | 183.01 Million | 20.33 Million |
| Other Investing Activities | -1 Million | -1 Million | 13.54 Million | 1.00 | -1.00 | 20.13 Million |
| Financing Cash Flow | 156 Thousand | 4.6 Million | 1.63 Million | 5.61 Million | 13.66 Million | 4.37 Million |
| Debt repayment | - | - | - | - | -5.81 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -6.24 Million | 4.6 Million | 1.63 Million | 5.61 Million | 19.48 Million | 4.37 Million |
| Other Financing Activities | 156 Thousand | 4.6 Million | 1.63 Million | 8.01 Million | -5.81 Million | 4.37 Million |
| Accounts receivables | 7.68 Million | 122 Thousand | 23.51 Million | -10.97 Million | -10.61 Million | -16.16 Million |
| Accounts payables | 4.33 Million | 1.12 Million | 4.58 Million | -3.2 Million | -6.01 Million | -4.12 Million |
| Inventory | -4.26 Million | -5.19 Million | -9.93 Million | 7.61 Million | 7.87 Million | 2.56 Million |
| Other working capital | 5.23 Million | -112 Thousand | -24.45 Million | 23.63 Million | 26.1 Million | 33.89 Million |
| Cash at beginning of period | 379.82 Million | 355.78 Million | 359.28 Million | 311.76 Million | 222.37 Million | 327.37 Million |
| Cash at end of period | 398.15 Million | 379.82 Million | 355.78 Million | 359.28 Million | 359.28 Million | 311.76 Million |
| Capital Expenditure | -3.88 Million | -3.87 Million | -2.91 Million | -3.45 Million | -49.52 Million | -15.43 Million |
| Effect of forex changes on cash | 156 Thousand | -3000.00 | -48 Thousand | 77 Thousand | -33 Thousand | -85 Thousand |
| Net cash flow / Change in cash | 18.33 Million | 24.04 Million | -3.5 Million | 47.52 Million | 136.9 Million | -15.61 Million |
| Free Cash Flow | 17.75 Million | 3.61 Million | -18.63 Million | 22.3 Million | -64.72 Million | -40.74 Million |
PLX
NBG6
2440
EMAMIREAL
4001
0IGA